104 related articles for article (PubMed ID: 25715636)
1. [Involvement of the dopaminergic system in the mechanisms of immunomodulation].
Al'perina EL
Usp Fiziol Nauk; 2014; 45(3):45-56. PubMed ID: 25715636
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory Effects Mediated by Dopamine.
Arreola R; Alvarez-Herrera S; Pérez-Sánchez G; Becerril-Villanueva E; Cruz-Fuentes C; Flores-Gutierrez EO; Garcés-Alvarez ME; de la Cruz-Aguilera DL; Medina-Rivero E; Hurtado-Alvarado G; Quintero-Fabián S; Pavón L
J Immunol Res; 2016; 2016():3160486. PubMed ID: 27795960
[TBL] [Abstract][Full Text] [Related]
3. Brain neurotensin, psychostimulants, and stress--emphasis on neuroanatomical substrates.
Geisler S; Bérod A; Zahm DS; Rostène W
Peptides; 2006 Oct; 27(10):2364-84. PubMed ID: 16934369
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptides in the immunomodulation: substance P-induced stimulation of immune response in mice.
Cheido M; Idova G
Int J Immunopharmacol; 1997; 19(9-10):529-33. PubMed ID: 9637349
[TBL] [Abstract][Full Text] [Related]
5. Involvement of brain dopaminergic structures in neuroimmunomodulation.
Devoino L; Alperina E; Galkina O; Ilyutchenok R
Int J Neurosci; 1997 Oct; 91(3-4):213-28. PubMed ID: 9394228
[TBL] [Abstract][Full Text] [Related]
6. The dopaminergic response to acute stress in health and psychopathology: A systematic review.
Vaessen T; Hernaus D; Myin-Germeys I; van Amelsvoort T
Neurosci Biobehav Rev; 2015 Sep; 56():241-51. PubMed ID: 26196459
[TBL] [Abstract][Full Text] [Related]
7. [Activation of dopaminergic system stimulates an immune response in mice with opposite type of behaviour].
Idova GV; Cheĭdo MA; Zhukova EN; Devoĭno LV
Ross Fiziol Zh Im I M Sechenova; 2002 Nov; 88(11):1394-400. PubMed ID: 12587267
[TBL] [Abstract][Full Text] [Related]
8. [Brain dopamine receptors: structure, functional role, and modulation by psychotropic substances].
Raevskiĭ KS
Vopr Med Khim; 1997; 43(6):553-65. PubMed ID: 9503573
[TBL] [Abstract][Full Text] [Related]
9. Contribution of brain dopamine, serotonin and opioid receptors in the mechanisms of neuroimmunomodulation: evidence from pharmacological analysis.
Idova GV; Alperina EL; Cheido MA
Int Immunopharmacol; 2012 Apr; 12(4):618-25. PubMed ID: 22406177
[TBL] [Abstract][Full Text] [Related]
10. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.
Clark D; White FJ
Synapse; 1987; 1(4):347-88. PubMed ID: 2971273
[TBL] [Abstract][Full Text] [Related]
11. Commentary: What does immunology have to do with brain development and psychopathology?--a commentary on O'Connor et al. (2014).
Leckman JF
J Child Psychol Psychiatry; 2014 Jun; 55(6):632-4. PubMed ID: 24840172
[No Abstract] [Full Text] [Related]
12. Neuroimmunomodulation in asthma: focus on the hypothalamic-pituitary-adrenal axis. Introduction.
Priftis KN; Chrousos GP
Neuroimmunomodulation; 2009; 16(5):263-4. PubMed ID: 19571586
[No Abstract] [Full Text] [Related]
13. Distribution of dopamine D1 and D2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents.
Dewar KM; Reader TA
Synapse; 1989; 4(4):378-86. PubMed ID: 2532424
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in corticolimbic dopamine and serotonin systems in the rat and the effect of postnatal handling.
Duchesne A; Dufresne MM; Sullivan RM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):251-61. PubMed ID: 19100810
[TBL] [Abstract][Full Text] [Related]
15. Mesocortical dopamine and HPA axis regulation: role of laterality and early environment.
Sullivan RM; Dufresne MM
Brain Res; 2006 Mar; 1076(1):49-59. PubMed ID: 16483551
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota: A Perspective for Psychiatrists.
Rea K; Dinan TG; Cryan JF
Neuropsychobiology; 2020; 79(1):50-62. PubMed ID: 31726457
[TBL] [Abstract][Full Text] [Related]
17. Neurobiology of dopamine in schizophrenia.
Guillin O; Abi-Dargham A; Laruelle M
Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
[TBL] [Abstract][Full Text] [Related]
18. [Psycho-neuro-immuno-endocrinological psychiatry].
Lopez-Mato AM; Boullosa O; Márquez C; Illa G; Vieitez A
Vertex; 2001; 12 Suppl 1():14-25. PubMed ID: 11780159
[No Abstract] [Full Text] [Related]
19. Dopaminergic drugs and ovulation: studies on PMS-induced ovulation and changes in median eminence DA and NE turnover in immature female rats.
Agnati L; Fuxe K; Löfstöm A; Hökfelt T
Adv Biochem Psychopharmacol; 1977; 16():159-68. PubMed ID: 883540
[No Abstract] [Full Text] [Related]
20. [Mental disorders and prolactin secretion].
Kordon C; Ruberg M
Encephale; 1979; 5(2):115-20. PubMed ID: 477592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
